A Review of Mutation Analysis In the TOPS Trial of Standard Dose Versus High Dose IM In CML Suggests That Refinements to the ELN Recommendations for Mutation Screening May Be Appropriate
Published online October 12, 2015.Susan Branford, Hyun-Gyung Goh, Barbara Izzo, Lan Beppu, Christine-Elke Ortmann, Kamila Duniec, Yu Jin, Richard C. Woodman, Fabrizio Pane, Dong-Wook Kim, Jerald P. Radich, and Timothy P. Hugheshttp://ash.confex.com/ash/2010/webprogram/Paper31856.htm